Alzheimer’s Prevention

It’s Never Too Early.

Changes in the brains of people with Alzheimer’s Disease can begin up to 20 years before symptoms appear. TRAILRUNNER-ALZ 3 is a clinical research study for people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease.

To be eligible you must:

  • Be between the ages of 55 and 80
  • Have no to mild issues with your memory
  • Have a blood test result that indicates the presence of early Alzheimer’s disease at study screening
  • Be willing to travel to Ocala, FL for in-person visits

Those that qualify may:

  • Receive access to potential new treatment options before the general public
  • Receive study-related diagnostic tests, lab work and medical exams provided at no cost
  • Receive compensation for time and travel associated with participation

No insurance is required to participate.

For more information, and to see if you qualify, please contact us today!
  • Please do NOT enter 1 before the area code.
  • This field is for validation purposes and should be left unchanged.
Lipoprotein(a)
Idiopathic Pulmonary Fibrosis (IPF)